Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast
New York, Jan 21, 2026, 11:32 EST — Regular session Shares of Johnson & Johnson fell roughly 1.3% to $215.31 in late morning trading Wednesday, following the company’s release of its 2026 forecast alongside fourth-quarter earnings. The outlook offers an early glimpse into Big Pharma’s growth plans for 2026. J&J features heavily in many long-only portfolios, so any slip on…